NASDAQ: HCM
Hutchmed Ltd Stock Ownership - Who owns Hutchmed?

Insider buying vs selling

Have Hutchmed Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when HCM insiders and whales buy or sell their stock.

HCM Shareholders

What type of owners hold Hutchmed Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Schroder Investment Management Group0.28%2,467,129$36.17MInstitution
Allianz Asset Management Gmbh0.10%908,804$13.32MInstitution
Jane Street Group LLC0.04%340,339$4.99MInstitution
State Street Corp0.04%317,504$4.65MInstitution
Amundi0.03%223,330$3.27MInstitution
Mg PLC0.02%204,432$3.00MInstitution
Ubs Group Ag0.02%137,000$2.01MInstitution
Renaissance Technologies LLC0.02%131,000$1.92MInstitution
Millennium Management LLC0.01%82,309$1.21MInstitution
Gts Securities LLC0.01%82,132$1.20MInstitution

1 of 3

HCM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HCM0.62%0.00%
SUPN45.48%54.52%Net BuyingNet Buying
AVDL81.74%13.55%Net Buying
PBH68.83%31.17%Net Selling
BHC51.13%48.87%Net BuyingNet Selling

Hutchmed Stock Ownership FAQ

Who owns Hutchmed?

Hutchmed (NASDAQ: HCM) is owned by 0.62% institutional shareholders, 0.00% Hutchmed insiders, and 99.38% retail investors. Schroder Investment Management Group is the largest individual Hutchmed shareholder, owning 2.47M shares representing 0.28% of the company. Schroder Investment Management Group's Hutchmed shares are currently valued at $35.85M.

If you're new to stock investing, here's how to buy Hutchmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.